Skip to main content
Top
Published in: Clinical Rheumatology 5/2014

01-05-2014 | Review Article

Can traumatic injury trigger psoriatic arthritis? A review of the literature

Authors: Jane Hsieh, Sabeeda Kadavath, Petros Efthimiou

Published in: Clinical Rheumatology | Issue 5/2014

Login to get access

Abstract

Traumatic injury as a trigger for the subsequent development of psoriatic arthritis (PsA) has been implicated by several case reports and case series. However, it is still unclear whether trauma is the inciting event or just an incidental finding. It is thought that the interplay of genetic, immunologic, and environmental factors, such as trauma, may trigger the development of PsA. At least two hypotheses of how trauma may be linked to the development of PsA have surfaced and involve a “deep Koebner effect,” the concept of a synovio-entheseal complex and activation of the innate immune system by biomechanical factors. The role of neuropeptides such as substance P and vasoactive intestinal peptide has been highlighted in the synovium after trauma. Better understanding of this phenomenon would shed light into the pathophysiology of Psa and help the development of preventive and therapeutic strategies.
Literature
2.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef
4.
go back to reference Melski JW, Bernhard JD, Stern RS (1983) The Koebner (isomorphic) response in psoriasis. Associations with early age at onset and multiple previous therapies. Arch Dermatol 119(8):655–659PubMedCrossRef Melski JW, Bernhard JD, Stern RS (1983) The Koebner (isomorphic) response in psoriasis. Associations with early age at onset and multiple previous therapies. Arch Dermatol 119(8):655–659PubMedCrossRef
5.
go back to reference Stankler L (1969) An experimental investigation on the site of skin damage inducing the Koebner reaction in psoriasis. Br J Dermatol 7:534–535CrossRef Stankler L (1969) An experimental investigation on the site of skin damage inducing the Koebner reaction in psoriasis. Br J Dermatol 7:534–535CrossRef
8.
go back to reference Kobner H (1876) Aetiologie der Psoriasis. Vjschr Dermatol Syphilis 3:559–561 Kobner H (1876) Aetiologie der Psoriasis. Vjschr Dermatol Syphilis 3:559–561
10.
go back to reference Saini R, Tutrone WD, Strober BE (2003) The Köbner phenomenon and psoriatic arthritis. Cutis 72(5):405–406, Review. PubMed PMID: 14655783PubMed Saini R, Tutrone WD, Strober BE (2003) The Köbner phenomenon and psoriatic arthritis. Cutis 72(5):405–406, Review. PubMed PMID: 14655783PubMed
11.
go back to reference Lories RJ, de Vlam K (2012) Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? Curr Rheumatol Rep 14(4):375–382PubMedCrossRef Lories RJ, de Vlam K (2012) Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? Curr Rheumatol Rep 14(4):375–382PubMedCrossRef
12.
go back to reference McGonagle D, Lories RJ, Tan AL, Benjamin M (2007) The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56(8):2482–2491PubMedCrossRef McGonagle D, Lories RJ, Tan AL, Benjamin M (2007) The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56(8):2482–2491PubMedCrossRef
13.
go back to reference McGonagle D, Conaghan PG, Emery P (1999) Psoriatic arthritis: a unified concept twenty years on. Arthritis & Rheumatism 42(6):1080–1086CrossRef McGonagle D, Conaghan PG, Emery P (1999) Psoriatic arthritis: a unified concept twenty years on. Arthritis & Rheumatism 42(6):1080–1086CrossRef
14.
go back to reference McGonagle DG, Helliwell P, Veale D (2012) Enthesitis in psoriatic disease. Dermatology 225:100–109PubMedCrossRef McGonagle DG, Helliwell P, Veale D (2012) Enthesitis in psoriatic disease. Dermatology 225:100–109PubMedCrossRef
15.
go back to reference McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ (2011) The early phase of psoriatic arthritis. Ann Rheum Dis 70(Suppl 1):i71–i76PubMedCrossRef McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ (2011) The early phase of psoriatic arthritis. Ann Rheum Dis 70(Suppl 1):i71–i76PubMedCrossRef
16.
go back to reference Fearon U, Veale DJ (2001) Pathogenesis of psoriatic arthritis. Clinical & Experimental Dermatology 26(4):333–337CrossRef Fearon U, Veale DJ (2001) Pathogenesis of psoriatic arthritis. Clinical & Experimental Dermatology 26(4):333–337CrossRef
17.
go back to reference Eedy DJ, Johnston CF, Shaw C, Buchanan KD (1991) Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 96(4):434–438PubMedCrossRef Eedy DJ, Johnston CF, Shaw C, Buchanan KD (1991) Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 96(4):434–438PubMedCrossRef
18.
19.
go back to reference Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235(4791):893–895PubMedCrossRef Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235(4791):893–895PubMedCrossRef
20.
go back to reference Veale D, Farrell M, Fitzgerald O (1993) Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol 32(5):413–416PubMedCrossRef Veale D, Farrell M, Fitzgerald O (1993) Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol 32(5):413–416PubMedCrossRef
21.
go back to reference Kane D, Lockhart JC, Balint PV, Mann C, Ferrell WR, McInnes IB (2005) Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint). Ann Rheum Dis 64:325–327PubMedCentralPubMedCrossRef Kane D, Lockhart JC, Balint PV, Mann C, Ferrell WR, McInnes IB (2005) Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint). Ann Rheum Dis 64:325–327PubMedCentralPubMedCrossRef
22.
go back to reference Mulherin D, Bresnihan B, FitzGerald O (1995) Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J Rheumatol 22(6):1211–1212PubMed Mulherin D, Bresnihan B, FitzGerald O (1995) Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J Rheumatol 22(6):1211–1212PubMed
23.
go back to reference Scarpa R, Del Puente A, di Girolamo C, della Valle G, Lubrano E, Oriente P (1992) Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis 51(1):78–79PubMedCentralPubMedCrossRef Scarpa R, Del Puente A, di Girolamo C, della Valle G, Lubrano E, Oriente P (1992) Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis 51(1):78–79PubMedCentralPubMedCrossRef
24.
go back to reference Punzi L, Pianon M, Bertazzolo N et al (1998) Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients. Clin Exp Rheumatol 16(3):277–281PubMed Punzi L, Pianon M, Bertazzolo N et al (1998) Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients. Clin Exp Rheumatol 16(3):277–281PubMed
25.
go back to reference Thumboo J, Uramoto K, Shbeeb MI et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 29(4):757–762PubMed Thumboo J, Uramoto K, Shbeeb MI et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 29(4):757–762PubMed
26.
go back to reference Eder L, Law T, Chandran V et al (2011) Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 63(8):1091–1097PubMedCrossRef Eder L, Law T, Chandran V et al (2011) Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 63(8):1091–1097PubMedCrossRef
27.
29.
go back to reference Miller JL, Soltani K, Tourtellotte CD (1971) Psoriatic acro-osteolysis without arthritis. A case study. J Bone Joint Surg Am Mar 53(2):371–374 Miller JL, Soltani K, Tourtellotte CD (1971) Psoriatic acro-osteolysis without arthritis. A case study. J Bone Joint Surg Am Mar 53(2):371–374
30.
go back to reference Langevitz P, Buskila D, Gladman DD (1990) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 17(5):695–697PubMed Langevitz P, Buskila D, Gladman DD (1990) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 17(5):695–697PubMed
31.
go back to reference Goupille P, Soutif D, Valat JP (1991) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 18(4):633PubMed Goupille P, Soutif D, Valat JP (1991) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 18(4):633PubMed
32.
go back to reference Olivieri I, Gemignani G, Christou C, Semeria R, Giustarini S, Pasero G (1991) The triggering role of physical injury in the onset of peripheral arthritis in seronegative spondyloarthropathy. Rheumatol Int 10(6):251–253PubMedCrossRef Olivieri I, Gemignani G, Christou C, Semeria R, Giustarini S, Pasero G (1991) The triggering role of physical injury in the onset of peripheral arthritis in seronegative spondyloarthropathy. Rheumatol Int 10(6):251–253PubMedCrossRef
33.
go back to reference Doury P (1993) Psoriatic arthritis with physical trauma. J Rheumatol 20(9):1629PubMed Doury P (1993) Psoriatic arthritis with physical trauma. J Rheumatol 20(9):1629PubMed
34.
go back to reference Padula A, Belsito F, Barozzi L et al (1999) Isolated tenosynovitis associated with psoriasis triggered by physical injury. Clin Exp Rheumatol 17(1):103–104PubMed Padula A, Belsito F, Barozzi L et al (1999) Isolated tenosynovitis associated with psoriasis triggered by physical injury. Clin Exp Rheumatol 17(1):103–104PubMed
35.
go back to reference Taylor-Gjevre RM, Nair B, Gjevre J, Leswick D (2012) Trauma and psoriatic arthritis: is there a relationship? Can Fam Physician 58(11):e636–e640PubMedCentralPubMed Taylor-Gjevre RM, Nair B, Gjevre J, Leswick D (2012) Trauma and psoriatic arthritis: is there a relationship? Can Fam Physician 58(11):e636–e640PubMedCentralPubMed
36.
go back to reference Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann Rheum Dis 67(5):672–676PubMedCrossRef Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann Rheum Dis 67(5):672–676PubMedCrossRef
Metadata
Title
Can traumatic injury trigger psoriatic arthritis? A review of the literature
Authors
Jane Hsieh
Sabeeda Kadavath
Petros Efthimiou
Publication date
01-05-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2436-7

Other articles of this Issue 5/2014

Clinical Rheumatology 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine